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Objectives The aim of this study was to evaluate Fontan peri-operative outcomes for 771 consecutive patients.
Background Since the initial description by Fontan, mortality associated with the Fontan operation has declined substantially.
However, postoperative effusions remain a significant challenge. Effusions are a key determinant of postopera-
tive length-of-stay and have been shown to be associated with the development of protein-losing enteropathy
and with decreased survival.
Methods This study was a single-center, retrospective review of 771 patients who underwent Fontan palliation from
1992 to 2009.
Results Patients were divided into 3 eras dictated by shift in clinical practice. Overall mortality was 3.5%, 1% since
1996. Importantly, age at Stage II palliation decreased from Era 1 to Era 3 (7.1 vs. 5.9 months; p 0.0001), whereas
age at Fontan increased (1.7 vs. 2.8 years; p  0.0001). The proportion of patients with prolonged hospital stay
(46.7% vs. 8.2% vs. 19.5%, p  0.001) decreased substantially after Era 1. A diagnosis of hypoplastic left heart
syndrome and longer operative support times were associated with prolonged pleural drainage (odds ratio [OR]:
2.17, p  0.001; OR: 1.2, p  0.001) and hospital stay (OR: 1.48, p  0.05; OR: 1.34, p  0.001). In patients
who underwent invasive assessment, higher pulmonary artery pressure was associated with death (OR: 1.37,
p  0.001) and prolonged hospital stay (OR: 1.09, p  0.019). Pulmonary arterial pressure 15 mm Hg was
90% specific for discriminating unfavorable outcomes.
Conclusions Mortality in the modern era is rare, whereas postoperative pleural drainage remains the dominant morbidity.
Elevated pulmonary artery pressure seems to be a marker of unfavorable outcome. Continued investigation is
warranted to determine whether medical interventions or alterations to operative strategy can alter peri-
operative results and improve long-term outcomes. (J Am Coll Cardiol 2012;60:1018–25) © 2012 by the
American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.05.010The concept of rerouting systemic venous return directly to
the pulmonary arteries for the palliation of congenital heart
disease was first described by Fontan and Kreutzer in the
early 1970s as an alternative approach for management of
tricuspid atresia (1,2). Since the original description, the
evolution of the “Fontan” has included numerous surgical
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2012, accepted May 1, 2012.advances, along with parallel advances in anesthesia man-
agement, perfusion strategies, and intra-operative and post-
operative care. In sum, these changes have led to substantial
reductions in early mortality (3–6) such that several recent
reports demonstrate mortality rates of 0% to 5.5% (7–11).
However, despite continued improvements, the incidence of
postoperative pleural effusions remains high and is a key
determinant of postoperative length-of-stay (7,9,11). Pro-
longed peri-operative course has been associated with the
late development of protein-losing enteropathy and with
decreased long-term survival, suggesting that improvements
in peri-operative course might have both short- and long-
term benefits (9). Factors previously shown to influence
peri-operative morbidity and mortality include: anatomy,
atrioventricular valve regurgitation, ventricular function,
pulmonary artery pressure (PAP), support times, modified
ultrafiltration (MUF), and Fontan type (12–15).
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September 11, 2012:1018–25 Long-Term Follow-Up of the Fontan OperationIn this study we review the peri-operative outcome for
771 consecutive patients after the Fontan operation at The
Children’s Hospital of Philadelphia from January 1, 1992,
to December 31, 2009. We identify trends in patient
characteristics, describe changes in surgical technique, and
evaluate the impact of these variables on early morbidity and
mortality with a goal of identifying factors that could be
modified to reduce early postoperative morbidity.
Methods
Data from all patients who underwent a first-time Fontan
operation during the study period were included. Demo-
graphic, anatomic, and procedural variables were recorded
from the medical record. In reporting procedural variables,
total support time (TST) represents the time circulation was
supported or arrested, equal to cardiopulmonary bypass
(CPB) plus deep hypothermic circulatory arrest (DHCA). If
multiple periods of CPB and DHCA were used, the times
were summed. Duration of pleural drainage was defined as
total days from surgery to removal of final chest tube or
drain or final thoracentesis, performed during initial admis-
sion or during a readmission within 30 days of surgery.
Hospital length-of-stay was defined as total days of initial
hospital stay plus any additional days during readmission(s)
within 30 days of surgery. The Institutional Review Board
at The Children’s Hospital of Philadelphia approved this
study.
Surgical technique. The surgical strategies for both the
superior cavo-pulmonary connection and the Fontan pro-
cedure were not standardized and have evolved considerably
over the time period of this study. Because 8 different
surgeons were involved in the care of these patients, multi-
ple different techniques have been used with regard to the
Figure 1 Number of Fontan Operations Performed/Year During
The blue represents intra-atrial lateral tunnel (LT) conduits, and the red representscreation of pathway fenestra-
tions, the use of patch material to
augment the branch pulmonary
arteries, and the timing and style
of cardiopulmonary bypass. Man-
agement of cardiopulmonary by-
pass and myocardial protection
were at the discretion of each
surgeon, as were the specific sur-
gical techniques used.
Statistical analysis. All demo-
graphic, anatomic, clinical, oper-
ative, and postoperative variables
were summarized with standard
descriptive statistics and ex-
pressed as mean  SD for nor-
ally distributed continuous
ariables, median (with range)
or skewed continuous variables,
nd count (with percentage) for
ategorical variables. Differences
cross eras, described in the fol-
owing text, were assessed with
nalysis of variance, Kruskal-Wallis (nonparametric analog
f analysis of variance), or Pearson chi-square. Duration of
ospital stay and chest tube drainage were converted to
ichotomous variables on the basis of standards from
revious literature and from review of the distribution of our
ata. Associations between all potential covariates of inter-
st and dichotomous outcome measures were assessed in
nivariate testing with logistic regression. Multivariate lo-
istic regression was then used to identify factors indepen-
ently associated with outcomes. Covariates with a
tudy Period
cardiac (EC) conduits.
Abbreviations
and Acronyms
AVV  atrioventricular
valve
CPB  cardiopulmonary
bypass
DHCA  deep hypothermic
circulatory arrest
ECC  extracardiac
conduit
HLHS  hypoplastic left
heart syndrome
IALT  intra-atrial lateral
tunnel
MUF  modified
ultrafiltration
OR  odds ratio
PAP  pulmonary arterial
pressure
TCPC  total
cavopulmonary connection
TST  total support timeOur S
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Long-Term Follow-Up of the Fontan Operation September 11, 2012:1018–25Patient Comparison by EraTable 1 Patient Comparison by Era
n Overall 1992–1996 1997–2002 2003–2009 p Value
Patient demographic data
Total cases 771 771 (100.0%) 227 (29.4%) 195 (25.3%) 349 (45.3%)
Age at Fontan (yrs) 771 2.3 (0.9–38.4) 1.7 (0.9–31.2) 2 (1–29.1) 2.8 (1.3–38.4) 0.001
Age at Stage II (months) 747 6.4 (1.9–177.6) 7.1 (3.0–177.6) 6.5 (2.6–103.3) 5.9 (1.9–71.6) 0.001
Weight at Fontan (kg) 771 12 (5.8–120) 10.8 (5.8–120) 11.4 (6.7–49.3) 12.9 (9.2–59.2) 0.001
Time from Stage II to Fontan (months) 747 20.3 (3.7–155.9) 12.4 (3.7–117) 16.6 (7.6–88.8) 27.1 (11.3–155.9) 0.001
Patient characteristics
Heterotaxy 771 66 (8.6%) 17 (7.5%) 24 (12.3%) 25 (7.2%) 0.095
Common AVV 771 88 (11.4%) 20 (8.8%) 27 (13.9%) 41 (11.8%) 0.259
Ventricular morphology 761 0.012
RV 143 (18.8%) 31 (13.9%) 39 (20.5%) 73 (21.0%)
LV 229 (30.1%) 64 (28.7%) 51 (26.8%) 114 (32.8%)
Both 10 (1.3%) 0 (0.0%) 2 (1.1%) 8 (2.3%)
HLHS 379 (49.8%) 128 (57.4%) 98 (51.6%) 153 (44.0%) .006
Dominant RV (HLHS  RV) 761 522 (68.6%) 159 (71.3%) 137 (72.1%) 226 (64.9%) .135
Stage 1 palliation 770 492 (63.9%) 146 (64.3%) 125 (64.4%) 221 (63.3%) 0.955
Sano as initial palliation 771 56 (7.3%) 0 (0%) 0 (0%) 56 (16.1%) 0.001
Type of Stage II 771 0.001
Not staged 21 (2.7%) 6 (2.6%) 12 (6.2%) 3 (0.9%)
BDG 304 (39.4%) 8 (3.5%) 51 (26.2%) 245 (70.2%)
HF 382 (49.6%) 195 (85.9%) 108 (55.4%) 79 (22.6%)
Bilateral SCPC 49 (6.4%) 18 (7.9%) 20 (10.3%) 11 (3.2%)
Kawashima 14 (1.8%) 0 (0.0%) 3 (1.5%) 11 (3.2%)
DKS/shunt 1 (13.0%) 0 (0.0%) 1 (0.5%) 0 (0.0%)
Preoperative assessment
AVVR 714 0.001
None 392 (54.9%) 148 (65.5%) 115 (59.3%) 129 (43.9%)
Mild 235 (32.9%) 70 (31.0%) 55 (28.4%) 110 (32.9%)
Moderate 81 (11.3%) 7 (3.1%) 22 (11.3%) 52 (11.3%)
Severe 6 (0.8%) 1 (0.4%) 2 (1.0%) 3 (0.8%)
AVVR mild 714 87 (12.2%) 8 (3.5%) 24 (12.4%) 55 (18.7%) 0.001
Pre-Fontan catheterization 771 668 (86.6%) 219 (96.5%) 185 (94.9%) 264 (75.6%) 0.001
Mean PA pressure 624 11.3 2.9 11.4 2.8 10.9 2.8 11.5 3.2 0.1038
Ventricular EDP 614 7.5 2.7 7.5 2.6 6.6 2.5 8.1 2.8 0.001
Surgical characteristics
Fontan type—extracardiac 771 362 (47.0%) 10 (4.4%) 79 (40.5%) 273 (78.2%) 0.001
Fenestration performed 771 691 (89.6%) 198 (87.2%) 178 (91.3%) 315 (90.3%) 0.344
Fenestration type 767 0.001
None 80 (10.4%) 29 (13.0%) 17 (8.7%) 34 (9.7%)
Single punch or side-side 530 (69.1%) 38 (17.0%) 178 (91.3%) 314 (90.0%)
Other 157 (20.5%) 156 (70.0%) 0 (0.0%) 1 (0.3%)
Additional procedures performed 771 109 (14.1%) 5 (2.2%) 31 (15.9%) 73 (20.9%) 0.001
None 662 (85.9%) 222 (97.8%) 164 (84.1%) 276 (79.1%)
Arch augmentation 3 (0.4%) 1 (0.4%) 1 (0.5%) 1 (0.3%)
Atrial septectomy 22 (2.9%) 1 (0.4%) 9 (4.6%) 12 (3.4%)
AVV repair 24 (3.1%) 3 (1.3%) 8 (4.1%) 13 (3.7%)
Other 60 (7.8%) 0 (0.0%) 13 (6.7%) 47 (13.5%)
Use of DHCA 756 715 (94.6%) 227 (100.0%) 168 (86.2%) 320 (95.8%) 0.001
Use of MUF 763 561 (73.5%) 30 (13.2%) 191 (99.5%) 340 (98.8%) 0.001
Total support time (min) 771 64 (32–274) 59 (32–147) 62 (41–236) 66 (32–274) 0.001
CPB time (min) 756 39 (11–242) 31 (11–106) 40 (32–222) 40 (26–242) 0.001
ACC time (min) 771 26 (0–99) 27 (13–93) 22 (0–99) 27 (0–91) 0.001
DHCA time (min) 756 24 (0–93) 27 (13–93) 17 (0–80) 25 (0–59) 0.001
Values are n (%), median (range), or mean  SD.
ACC  aortic cross clamp; AVV  atrioventricular valve; AVVR  atrioventricular valve regurgitation; BDG  bidirectional Glenn; CPB  cardiopulmonary bypass; DHCA  deep hypothermic circulatory
rrest; DKS  Damus-Kaye-Stansel; EDP  end-diastolic pressure; HF  hemi-Fontan; HLHS  hypoplastic left heart syndrome; LV  left ventricle; MUF  modified ultrafiltration; PA  pulmonary artery;
V  right ventricle; SCPC  superior cavopulmonary connection.
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September 11, 2012:1018–25 Long-Term Follow-Up of the Fontan Operationp value of 0.2 on univariate analysis and observations in at
least 90% of subjects were considered for inclusion in the
multivariate analysis. Two clusters of highly collinear cova-
riates identified: TST, CPB, aortic cross clamp, and
DHCA; and era, Fontan type, and use of MUF. No more
than 1 variable from each collinear cluster was included in
the final multivariate model. When more than 1 variable
met inclusion criteria in the final model, the variable that
produced the model with the lowest Akaike Information
Criterion score (post-test goodness-of-fit measure) was
selected. Because pre-Fontan cardiac catheterization data
were available in 90% of subjects, sub-analysis was per-
formed to generate best-fitting multivariate models, includ-
ing catheter-derived variables and reported separately. Sta-
tistical significance was determined a priori as a 2-tailed
p value 0.05. All statistical analyses were performed with
STATA software (version 10, StataCorp., College Station,
Texas).
Results
A total of 771 patients underwent first-time Fontan oper-
ation at The Children’s Hospital of Philadelphia between
January 1, 1992 and December 31, 2009. The average
number of Fontan operations in a given year was 43. On the
basis of changes in clinical practice (outlined below), the
cohort was divided into 3 eras (Fig. 1): 1992 to 1996 (Era 1,
n 227), 1997 to 2002 (Era 2, n 195), and 2003 to 2009
Era 3, n  349). The eras represent introduction of MUF,
Outcome Comparison by EraTable 2 Outcome Comparison by Era
n Overall
Death 30 days 771 27 (3.5%)
Fontan takedown 771 8 (1.0%)
ICU duration (days) 750 3 (0–181)
Hospital duration (days) 771 8 (0–278)
Hospital stay 14 days 771 190 (24.6%)
Duration of effusion (days) 743 3 (1–258)
Effusion 14 days 743 134 (18.0%)
Values are count (% of total) or median (range).
ICU  intensive care unit.
Risk Factors for Death or Fontan Takedown WitTable 3 Risk Factors for Death or Fontan Ta
Univar
OR (95% CI)
Weight at Fontan (kg) 1.03 (1.003–1.06)
Time from stage II (months) 0.93 (0.88–0.98)
Common AVV 2.87 (1.20–6.60)
Fontan type: ECC vs. IALT 0.61 (0.30–1.30)
Fenestration 0.38 (0.16–0.90)
Use of MUF 0.14 (0.10–0.30)
TST (15 min) 1.24 (1.06–1.40)
ACC (15 min) 1.75 (1.30–2.30)
DHCA (15 min) 2.14 (1.60–2.90)CI confidence interval; ECC extracardiac conduit; IALT intra-atrial lateral
as in Table 1.hange in type of fenestration, and a shift toward the use of
he extracardiac conduit (ECC). In Era 1 most Fontan
ompletions were intra-atrial lateral tunnels (IALT). Era 2
as a transition period during which Fontan types were
argely balanced between IALT and ECC. In Era 3 most
ontan operations were ECC. Routine use of MUF was
ntroduced in 1996.
aseline patient characteristics at time of Fontan. De-
ographic, anatomic, preoperative, and operative character-
stics across era are outlined in Table 1. The distribution of
entricular morphology varied significantly across eras as the
verall proportion of subjects with hypoplastic left heart
yndrome (HLHS) decreased from 57.4% in Era 1 to 44.0%
n Era 3. In the most recent era the number of patients with
reater than mild atrioventricular valve regurgitation in-
reased significantly compared with the 2 older cohorts. In
hose who underwent preoperative cardiac catheterization,
here were significant differences in ventricular end-diastolic
ressure—highest in Era 3, and lowest in Era 2. There was
o significant difference in mean PAP across eras. An
ncrease in the use of bidirectional Glenn operation was
oted in the 2 most recent cohorts, mirroring the increased
se of the ECC. Age at Stage II palliation decreased over
he course of the study, leading to longer time between
tage II palliation and the Fontan.
Over the 18 years included in the review, Fontan type was
venly split between ECC and IALT (Table 1). During the
tudy period, no patient underwent an atrio-pulmonary
2–1996 1997–2002 2003–2009 p Value
(9.3%) 2 (1.0%) 4 (1.2%) 0.001
(1.3%) 1 (0.5%) 4 (1.2%) 0.69
(1–181) 2 (0–56) 3 (1–45) 0.001
(0–278) 6 (2–56) 8 (2–108) 0.001
(46.7%) 16 (8.2%) 68 (19.5%) 0.001
(1–258) 1 (1–40) 4 (1–71) 0.001
(28.6%) 14 (7.5%) 61 (17.5%) 0.001
0 Days of Fontanwn Within 30 Days of Fontan
Multivariate
p Value OR (95% CI) p Value
0.03
0.003
0.014 4.06 (1.50–11.20) 0.007
0.196
0.028
0.001 0.16 (0.06–0.44) 0.001
0.008
0.001
0.001 1.65 (1.10–2.40) 0.01199
21
3
3
12
106
3
59hin 3kedo
iatetunnel; OR odds ratio; TST total support time; other abbreviations
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Long-Term Follow-Up of the Fontan Operation September 11, 2012:1018–25connection. The median age at Fontan increased from
Era 1 to Era 3; as did weight at Fontan. The TST
increased over the 3 eras. Although the overall rate of
fenestration did not significantly change across era, the
use of single-punch or side-to-side fenestrations in-
creased significantly. The number of additional proce-
dures performed at the time of the Fontan was highest in
the most recent era.
Outcome comparisons across eras. The variations in out-
comes across eras are outlined in Table 2. In the complete
cohort there were 27 deaths before hospital discharge, and
within 30 days of the Fontan operation, there was a
peri-operative mortality rate of 3.5%. However, mortality
decreased significantly from Era 1 to Era 3. Overall, there
were 8 patients who required Fontan takedown, with no
significant variation by era. The largest proportion of
patients requiring hospital stay 14 days or with persistent
pleural drainage for 14 days occurred in Era 1 and
decreased substantially in Era 2 and Era 3.
Risk factors for death, prolonged hospital stay, and
prolonged effusion. Significant risk factors for death or
ontan takedown within 30 days of the Fontan operation
re outlined in Table 3 and include the presence of a
common atrioventricular valve (AVV) and longer DHCA.
The use of MUF was associated with decreased odds of
death or Fontan takedown within 30 days of Fontan. Risk
Risk Factors for Prolonged Hospital Stay (>14Table 4 Risk Factors for Prolonged Hospita
Univar
Variable OR (95% CI)
Age at Fontan (yrs) 0.80 (0.70–0.93)
Weight at Fontan (kg) 0.91 (0.86–0.97)
Time from Stage II (months) 0.96 (0.94–0.98)
Dominant RV 1.51 (1.04–2.20)
HLHS 1.64 (1.17–2.30)
Fontan type: ECC vs. IALT 0.65 (0.46–0.91)
Creation of fenestration 0.53 (0.33–0.87)
Use of MUF 0.15 (0.11–0.22)
TST (15 min) 1.11 (1.00–1.22)
ACC (15 min) 1.46 (1.23–1.73)
DHCA (15 min) 1.61 (1.33–1.95)
Abbreviations as in Tables 1 and 3.
Risk Factors for Prolonged Pleural Effusion (>1Table 5 Risk Factors for Prolonged Pleural
Univar
OR (95% CI)
Time from Stage II (months) 0.98 (0.96–0.997)
Dominant RV 1.80 (1.15–2.80)
HLHS 1.88 (1.28–2.76)
Creation of fenestration 0.49 (0.29–0.83)
Use of MUF 0.32 (0.21–0.47)
TST (15 min) 1.09 (0.98–1.20)
ACC (15 min) 1.27 (1.05–1.50)Abbreviations as in Tables 1 and 3.factors for prolonged hospital stay (14 days) are outlined
in Table 4 and include a diagnosis of HLHS and longer
TST. In contrast, older age at the time of Fontan, use of
fenestration, and MUF were associated with a lower occur-
rence of prolonged hospital stay. Risk factors associated
with prolonged effusion (14 days) are described in Table 5
nd include a diagnosis of HLHS and longer TST. Cre-
tion of a fenestration and use of MUF were associated with
decreased incidence of prolonged effusion. Results of the
ub-analysis of patients who received a preoperative cardiac
atheterization are shown in Table 6. Higher mean PAP
was an independent risk factor for death within 30 days and
hospital stay 14 days. In addition, although there was no
absolute cut-point, a PAP 15 mm Hg was 90% specific in
discriminating unfavorable outcomes for prolonged effusion,
length-of-stay, and death (Table 7).
Support time and Fontan type. Given the increased
length-of-stay and duration of effusion in the most recent
era and the identified association with longer TST, we
independently evaluated factors associated with increased
support times (Table 8). Multivariate analysis demon-
strated that ECC, need for additional procedures (such as
arch augmentation and atrioventricular valvuloplasty),
and larger patient size were independently associated
with longer TST.
(>14 Days)
Multivariate
p Value OR (95% CI) p Value
0.003 0.86 (0.78–0.95) 0.002
0.002
0.001
0.03
0.004 1.48 (1.00–2.18) 0.05
0.011
0.012 0.48 (0.27–0.84) 0.01
0.001 0.13 (0.09–0.20) 0.001
0.051 1.34 (1.19–1.52) 0.001
0.001
0.001
s)on (>14 Days)
Multivariate
p Value OR (95% CI) p Value
0.019
0.01
0.001 2.17 (1.43–3.30) 0.001
0.008 0.45 (0.26–0.79) 0.005
0.001 0.31 (0.21–0.47) 0.001
0.118 1.22 (1.08–1.37) 0.001
0.013Days)l Stay
iate4 DayEffusi
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September 11, 2012:1018–25 Long-Term Follow-Up of the Fontan OperationDiscussion
This study reviews changes in preoperative patient charac-
teristics and surgical techniques and evaluates the impact of
those changes on morbidity and mortality for 771 consec-
utive patients undergoing the Fontan operation over an
18-year period at a single institution. This is the largest
contemporary report of peri-operative outcomes after the
Fontan operation. In this cohort, overall mortality remained
approximately 1% from 1996 to 2009, with duration of
pleural tube drainage and length-of-stay that compare
favorably with other contemporary reports (Table 9) (7–11).
Interestingly, although overall mortality has remained low,
duration of pleural drainage and length-of-stay have both
increased slightly in the most recent era, likely related to an
increase in patient complexity and a change in practice
toward greater use of the ECC. Nevertheless, our results
demonstrate that in the current era the Fontan operation
can be performed with low early postoperative mortality and
relatively short hospital stays.
Changes in patient characteristics and surgical technique.
Over the 18 years of this study there has been an evolution
toward performing Stage II earlier and Fontan completion
later; possibly related to concern about inter-stage mortality
for children with shunt-dependent physiology (16,17) cou-
pled with the desire to place a sufficiently large ECC. In the
most recent era a higher proportion of patients had more
than mild AVV regurgitation, ventricular end-diastolic
pressure was significantly higher, and a higher proportion of
patients required additional procedures at the time of the
Fontan operation, suggesting that this might be a higher-
Multivariate Analysis of Cardiac Catheterization Subgroup (N  66Table 6 Multivariate Analysis of Cardiac Catheterization Subgr
Death < 30 Days (n  25)
Variable OR p Value
Age at Fontan (yrs)
HLHS
Common AVV 5.90 (1.80–18.90) 0.003
Use of MUF 0.05 (0.01–0.21) 0.001
Fenestration
TST (15 min)
DHCA (15 min) 1.47 (0.96–2.20) 0.077
Mean PA pressure (per mm Hg) 1.37 (1.20–1.60) 0.001
Abbreviations as in Tables 1 and 3.
Sensitivity and Specificity of PAP as a Predictor of Unfavorable OuTable 7 Sensitivity and Specificity of PAP as a Predictor of Un
Hospital Stay >14 Days
PAP Sensitivity Specificity S
6 mm Hg 99% 2%
9 mm Hg 91% 16%
12 mm Hg 52% 57%
15 mm Hg 18% 91%
18 mm Hg 5% 98%PAP  pulmonary arterial pressure.risk cohort. These changes in patient characteristics suggest
an improvement in the survival of more marginal patients
through the first 2 stages of palliation.
The most notable operative changes over this study
period were the introduction of MUF, the shift from the use
of an IALT to an ECC, and the shift to a single-punch or
side-to-side fenestration creation in the most recent eras.
The change in practice toward the use of ECC was
primarily based on the expectation that an ECC will provide
a better long-term outcome. Longer-term follow-up is
needed to determine whether the proposed benefit is indeed
valid.
Risk factors for death, prolonged hospital stay, and
prolonged effusion. A common AVV and longer DHCA,
both markers of surgical complexity, were associated with an
increased risk of death or takedown. A diagnosis of HLHS
and longer TST were associated with an increased risk of
both prolonged effusion and hospital stay. Our data confirm,
similar to other reports, the association of MUF and
fenestration with a decrease in morbidity and mortality after
Fontan (3). Sub-analysis of patients who had a preoperative
cardiac catheterization found that higher mean PAP, a
potential target for pharmacologic intervention, was also
associated with an increased risk of death or takedown and
prolonged hospital stay. Our analysis identified a PAP 15
m Hg as a good discriminator of unfavorable outcomes for
rolonged effusion, length-of-stay, and death.
upport time and Fontan type. We report an association
etween longer TST and both duration of hospital stay and
uration of pleural drainage. In addition, we found that
N  668)
Hospital >14 Days (n  171) Effusion >14 Days (n  115)
OR p Value OR p Value
0.83 (0.75–0.93) 0.002
2.36 (1.46–3.8) 0.001
0.10 (0.07–0.16) 0.001 0.26 (0.16–0.41) 0.001
0.50 (0.27–0.94) 0.03
1.30 (1.14–1.48) 0.001 1.23 (1.08–1.40) 0.002
1.09 (1.01–1.16) 0.019 1.07 (0.99–1.15) 0.09
eble Outcome
Effusion >14 Days Death Before Discharge
ity Specificity Sensitivity Specificity
2% 100% 1.5%
15% 96% 14%
56% 79% 56%
90% 46% 90%
98% 8% 97%8)oup (tcomfavora
ensitiv
99%
90%
51%
21%
5%
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and need for additional procedures at the time of the Fontan
operation. Although the need for additional procedures is
not easily modifiable, the use of ECC was a change in
practice predicated upon the potential long-term benefits
of ECC versus IALT. Given the increase in pleural
drainage and duration of hospital stay associated with use
of ECC, a definitive study evaluating its potential long-
term benefit would be useful to justify its continued
widespread use. Another potential option proposed by
some centers is to perform the Fontan operation without
use of CPB. However, reported results of “off-pump”
Fontan operations are similar to those reported herein
(11,18).
Study limitations. As a retrospective review, our analysis
was restricted to data recorded in patient charts and can
show only associations and not causality. In our analysis the
use of MUF, Fontan type, and era were among the collinear
variables, making the individual contributions of each vari-
able difficult to identify. The use of MUF produced the best
result on goodness-of-fit testing and therefore was used in
this analysis. Although we believe MUF has benefits, there
might be other unquantifiable changes across eras, such as
specialized nursing care and improvement in postoperative
medical management that also contributed significantly to
the improved outcomes. Furthermore, because of the rela-
tively small number of outcomes, there is a possibility of
over-fitting the final multivariate model for death or
takedown.
Conclusions
In this study we describe early postoperative outcomes for
771 consecutive patients after the Fontan operation over an
Variables Associated With Total Support TimeTable 8 Variables Associated With Total Su
Univa
Variable Coefficient (95% C
Age at Fontan 1.46 (0.9 to 2.0)
Weight at Fontan 0.66 (0.43 to 0.88
Single RV 3.95 (7.4 to0.
HLHS 8.1 (11.2 to4
Type of Stage II (BDG vs. HF) 18.3 (15.6 to 21.1
Type of Fontan (ECC vs. IALT) 18.7 (15.8 to 21.6
Additional Procedure at Fontan 8.2 (3.7 to 12.8)
Abbreviations as in Tables 1 and 3.
Summary of Contemporary Reports of Early Postoperative OutcomeTable 9 Summary of Contemporary Reports of Early Postoperat
Cohort Years n Mortality T
O’Brien et al. (7) 1997–2008 145 5.5%
Hirsch et al. (9) 1992–2007 636 4.0%
Tweddell et al. (8) 1994–2007 256 2.0%
Salvin et al. (10) 2001–2005 226 0.9%Petrossian et al. (11) 1992–2005 285 1.1% 1.4%18-year period at a single institution. Importantly, despite
increasing patient complexity, mortality in this cohort was a
rare event, and morbidity, primarily in the form of pro-
longed pleural effusions, was similar to that reported in
other contemporary series. Nevertheless, although the use of
the ECC might have a theoretical benefit for the prevention
of late arrhythmias, in this cohort it was associated with
increased pleural drainage. Prolonged pleural drainage has
been associated with an increased incidence of protein-
losing enteropathy and with decreased survival. There-
fore, continued investigation is warranted to determine
whether further alterations to operative strategy or tar-
geted interventions aimed at decreasing pulmonary arte-
rial pressure might help to reduce pleural drainage,
decrease the frequency of late complications, and improve
long-term survival.
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